Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peroxisome Proliferator‐Activated Receptor Gamma Polymorphisms and Coronary Heart Disease

1 Jan 2009

Abstract excerpt

Single nucleotide polymorphisms (SNPs) in the peroxisome proliferator-activated receptor gamma (PPARG) gene have been associated with cardiovascular risk factors, particularly obesity and diabetes. We assessed the relationship between 4 PPARG SNPs (C-681G, C-689T, Pro12Ala, and C1431T) and coronary heart disease (CHD) in the PRIME (249 cases/494 controls, only men) and ADVANCE (1,076 cases/805 controls, men or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipose Tissue and Metabolism
Share to Metabolism, Diabetes, and Cancer
Share to Peroxisome Proliferator-Activated Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20016803
DOI: 10.1155/2009/543746

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peroxisome Proliferator‐Activated Receptor Gamma Polymorphisms and Coronary Heart DiseasePMID 20016803Read ↗

The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis.Semantic proximity Read ↗

PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery DiseaseSemantic proximity Read ↗

Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.Semantic proximity Read ↗

The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPARγ2) is associated with increased risk of coronary artery disease: a meta-analysis.Semantic proximity Read ↗

The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.Semantic proximity Read ↗

Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women.Semantic proximity Read ↗

PPARgamma promoter polymorphisms and acute coronary syndrome.Semantic proximity Read ↗

Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.Semantic proximity Read ↗

PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.Semantic proximity Read ↗

Functional Variant of C-689T in the Peroxisome Proliferator-Activated Receptor-γ2 Promoter is Associated with Coronary Heart Disease in Chinese Nondiabetic Han People.Semantic proximity Read ↗

Peroxisome proliferator‑activated receptor γ polymorphisms as risk factors for dyslipidemia.Semantic proximity Read ↗

Association of the PPARγ2 Pro12Ala polymorphism with increased risk of cardiovascular diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.